TRPM7 and ovarian carcinoma: Treatment with MG132, a proteasome inhibitor, remarkably restored HIF-1α protein levels in ovarian cancer cells regardless of hypoxia condition and TRPM7 silencing (Fig. 7B), indicating that TRPM7 silencing promoted the ubiquitination and proteasomal degradation of HIF-1α.